Alcohol drug hope for brain cancer

A drug for alcoholism may be able to help patients with brain cancer, British researchers revealed yesterday.

The drug, disulfiram, has been in use for 60 years.

Now laboratory studies in Wolverhampton suggest it has the key characteristics of a brain cancer drug.

Treatments for the disease must be able to cross the blood-brain barrier as well as tackling the cancer.

The research at Wolverhampton University suggests the drug can help sensitise cancer cells to existing treatments for the cancer glioblastoma. The studies suggest it could work well with the existing drug gemcitabine.

The drug works by moving copper into the brain.

The work has been backed by the Brain Tumour Charity, formerly the Samantha Dickson Brain Tumour Trust, and was published yesterday in the British Journal of Cancer.

Researcher Dr Weiguang Wang said: "The idea of using copper to tackle cancer was first suggested by UK scientists in the 1920s, but this is the first time that scientists have found a way of successfully transporting excess copper into cancer cells and shown how this can be combined with conventional chemotherapy treatment to help kill glioblastoma cells.

"We’ve been studying the cancer-fighting properties of disulfiram for over a decade, so it’s very exciting to have reached a stage where clinical trials may be possible.

"Glioblastoma cells tend to have much higher levels of copper than normal tissues, meaning additional copper may tip them over the edge while sparing normal tissues."

Peng Liu et al. Cytotoxic effect of disulfiram.copper on human glioblastoma cell lines and ALDH positive cancer-stem-like cells. British Journal of Cancer October 24 2012 doi:10.1038/bjc.2012.442

, ,

Leave a Reply

Your email address will not be published. Required fields are marked *

Search

Categories

Monthly Posts

Our Clients

BSH
Practice Index